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Introduction. In recent years, a phenomenon known as “vaccine 
hesitancy” has spread throughout the world, even among health 
workers, determining a reduction in vaccination coverage (VC). 
A study aimed at evaluating VC among healthcare workers 
(HCWs) in 10 Italian cities (L’Aquila, Genoa, Milan, Palermo, 
Sassari, Catanzaro, Ferrara, Catania, Naples, Messina) was per-
formed.
Materials and methods. Annex 3 of the Presidential Decree n. 
445 of 28 December 2000 was used to collect information on the 
vaccination status of HCWs. The mean and standard deviation 
(SD) were calculated with regard to the quantitative variable 
(age), while absolute and relative frequencies were obtained for 
categorical data (sex, professional profile, working sector, vac-
cination status). The connection between VC and the categorical 
variables was evaluated by chi-square method (statistical signifi-
cance at p < 0.05). The statistical analyses were performed by 
SPSS and Stata software.
Results. A total of 3,454 HCWs participated in the project: 1,236 
males and 2,218 females. 
The sample comprised: physicians (26.9%), trainee physicians 
(16.1%), nurses (17.2%) and other professional categories 
(9.8%). Low VC was generally recorded. Higher VC was found 
with regard to polio, hepatitis B, tetanus and diphtheria, while 
coverage was very low for measles, mumps, rubella, pertussis, 
chickenpox and influenza (20-30%). 
Conclusions. This study revealed low VC rates among HCWs for 
all the vaccinations. Measures to increase VC are therefore neces-
sary in order to prevent HCWs from becoming a source of trans-
mission of infections with high morbidity and/or mortality both 
within hospitals and outside.
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Introduction 
Although vaccination is widely considered to be an ef-
ficacious and cost-effective health technology, the phe-
nomenon known as ‘vaccine hesitancy’ is spreading, not 
only among citizens, but also among healthcare workers 
(HCWs), with a consequent steady reduction in vaccine 
coverage (VC) [1-8]. This is a serious health problem, 
as HCWs may spread infections to patients, colleagues 
and relatives. Indeed, low VC among HCWs can lead 
to dangerous outbreaks of disease, reduce productivity 
and increase absenteeism [9-11]. HCWs are therefore a 
priority target group for vaccinations [12-14].
Inadequate vaccination coverage among HCWs is a ma-
jor concern for all national healthcare organizations. The 
World Health Organization (WHO) estimates that ap-
proximately 59 million HCWs worldwide are potentially 
exposed to hazardous biological agents daily [13]. In Eu-
rope, the average VC among HCWs is very low [3]. As 
recommended by the WHO Strategic Advisory Group of 
Experts (SAGE), vaccine hesitancy, and thus VC, need 
to be evaluated both globally and locally  [1, 2].
The 2017-2019 Italian National Immunization Preven-
tion Plan (INIPP) strongly recommends that HCWs be 
vaccinated [14]. However, although data are not system-
atically available, VC among HCWs is estimated to be 
very low. Indeed, only few studies have been conducted 
on this issue, and these have concerned a limited number 
of hospitals and are clearly not representative of the na-
tional scenario in Italy. One systematic review regarding 
Italy revealed suboptimal VC for hepatitis B and mea-
sles, and very low VC for varicella (3.6%) and influ-
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enza (10-25%) [15]. Similarly, a study from the Puglia 
region found tetanus-diphtheria vaccination uptake to 
be only15.5% [16]. Another study, published in 2015, 
reported an influenza vaccination uptake of 16% among 
HCWs [17].
In 2017, in accordance with the INIPP, a committee of 
Italian experts drafted “The Pisa Charter of Vaccina-
tions”, which identified the main pillars of a strategy to 
boost VC among HCWs [18].
Law 119/2017, concerning “Urgent provisions on vac-
cination prevention, infectious diseases and disputes re-
lated to the administration of drugs” [19], and Ministerial 
Circular 25233 of 16 August 2017 required that data be 
collected on the vaccination status of workers in schools, 
healthcare and social care. Indeed, as required by Presi-
dential Decree 445 of 28 December 2000, teachers, social 
workers and HCWs must submit a report of their vaccina-
tion status to the institutions for which they work. How-
ever, despite these legal measures, vaccinations have 
not become mandatory for HCWs. Hence, healthcare 
professionals are under no legal obligation to be vac-
cinated [20-22].
The aim of our study was to investigate the VC of HCWs 
at several academic hospitals in Italy.
Materials and methods 
A multicenter cross-sectional study was conducted from 
March to September 2018 in the following 10 cities: 
L’Aquila, Genoa, Milan, Palermo, Sassari, Catanzaro, 
Ferrara, Catania, Naples and Messina.
Ethical approval was obtained from the Ethics Com-
mittee of the University Hospital “AOU G. Martino di 
Messina”. Written informed consent was obtained from 
all subjects before participation in the study.
Annex 3 of Presidential Decree n. 445 28 December 
2000 was used to collect information on the vaccination 
status of HCWs [22]. Statistical analysis of the param-
eters considered relevant was performed. The mean and 
standard deviation (SD) were calculated with regard to 
the quantitative variable (age), while absolute and rela-
tive frequencies were obtained for categorical data (sex, 
professional profile, working sector, vaccination status).
All possible associations between VC and the data col-
lected (sex, professional profile, working sector, vacci-
nation status were investigated; 2 x 2 contingency tables 
were constructed, and assumptions were tested by means 
of the chi-square method. Statistical significance thresh-
old was set at p = 0.050; p-values of less than 0.050 on 
two-tailed tests were considered statistically significant. 
The summary and inferential statistics were analyzed by 
means of SPSS and Stata software.
Results
A total of 3,454 HCWs participated in the study: 1,236 
males and 2,218 females.
The sample comprised physicians (26.9%), physicians 
in training (16.1%), nurses (17.2%) and other profes-
sional categories (9.8%). In 30% of cases, the respond-
ents did not state their profession.
The mean age of the whole sample was 45.85 years 
(SD: 11.82; CI: 45.45-46.24; IQR: 21.8). The mean 
age of male subjects was 46.39 years (SD: 12.67; CI: 
45.68-47.10; IQR: 24.6), and of females 45.55 years 
(SD: 11.32; CI: 45.08-46.02; IQR: 20.9). The sample 
was also stratified by age-group: 20-30 years (11.61%), 
31-40 (24.2%), 41-50 (22.32%), 51-60 (28.31%), ≥ 61 
(12.88%); 0.68% of the sample did not state their age.
The sample was divided into three working areas: clini-
cal (32.7%), surgical (29.8%) and services (21.9%); 
15.6% of the sample did not provide information on this 
item.
Regarding the provenance of the respondents: 6.5% 
were from the north of Italy, 1.1% from the central re-
gions and 67.2% from the south; 873 subjects (25.3%) 
did not report their region of birth.
Evaluation of replies regarding immunization status re-
vealed inadequate VC, i.e. below 95% for all vaccina-
tions examined. Higher VC was found with regard to 
polio, hepatitis B, tetanus and diphtheria, while cover-
age was very low for measles, mumps, rubella, pertus-
sis, chickenpox and influenza (20-30%); lower VC rates 
were found for vaccinations not specifically recom-
mended for HCWs (i.e. herpes zoster, meningococcus). 
Many HCWs could not remember or did not report their 
immunization status (Tab. I).
The vaccinations that are not specifically recommended 
for HCWs were excluded from the next statistical analy-
sis (H. influenzae, Meningococcus C, Meningococcus 
B, Pneumococcus, Hepatitis A, Papilloma virus, Herpes 
zoster, Tuberculosis).
Differences of coverage rates considering sex, age, 
working area and professional category were analyzed. 
For these analyses the category “not reported or not re-
member” was excluded.
Regarding to sex we did not find significant differences 
except to rubella, chickenpox and mumps. Men HCWs 
showed higher vaccine coverage than women.
Concerning age, we evaluated the difference of cover-
age rates for the following vaccines: polio, diphtheria, 
tetanus, hepatitis B, pertussis, measles, rubella, mumps, 
influenza considering five age-groups. Vaccination cov-
erage by age is shown in Table II. Significant differences 
were found for poliomyelitis, tetanus, pertussis and in-
fluenza. 51-60 age-class showed higher VC for polio-
myelitis, diphtheria and tetanus, while higher VC for 
influenza was detect in ≥ 61 years subjects.
Excluding HCWs who did not report their working sec-
tor, we evaluated the vaccination coverage for the fol-
lowing vaccines: polio, diphtheria, tetanus, hepatitis 
B, pertussis, measles, rubella, mumps, chickenpox and 
influenza (Tab. III). Significant differences were found 
only for hepatitis B vaccine.
Excluding HCWs who did not reported their profession-
al profile, we evaluated the vaccination coverage for the 
following vaccines: polio, diphtheria, tetanus, hepatitis 
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B, pertussis, measles, rubella, mumps, chickenpox and 
influenza (Tab. IV). Significant differences were found 
for polio, diphtheria, hepatitis B, rubella and chicken-
pox. Physicians showed significant higher coverage than 
nurses and other healthcare workers for hepatitis B and 
rubella.
Regarding to influenza vaccination the highest cover-
age was found in other professional categories respect to 
physicians and nurses.
Discussion and conclusions
This study revealed low VC rates among HCWs for all the 
vaccinations. Such coverage rates are totally inadequate in 
terms of preventing not only disease transmission by sus-
ceptible HCWs, but also nosocomial outbreaks, an exam-
ple being the recent outbreaks of measles in Italy [23, 24] 
confirming data from previous studies at the national and 
international levels [3, 7, 8, 12, 16, 17, 25, 26].
Tab. I. Vaccination coverage and natural immunity reported by HCWs, broken down by type of vaccination.
Not vaccinated (%, CI) Vaccinated (%, CI) Not reported (%, CI)
Natural immunity (%, 
CI)
Poliomyelitis 3.1 (2.55-3.71) 80.0 (78.69-81.36) 16.9 (15.55-18.04) 0.0
Diphtheria 6.2 (5.42-7.03) 72.4 (70.95-73.93) 21.3 (19.94-22.67) 0.0
Tetanus 5.9 (5.09-6.66) 76.8 (75.34-78.16) 17.3 (16.08-18.60) 0.0
Hepatitis B 9.6 (8.60-10.56) 77.3 (75.93-78.73) 12.5 (11.43-13.64) 0.6 (0.35-0.86)
Pertussis 33.9 (33.35-35.51) 29.5 (27.95-30.99) 31.6 (30.056-33.17) 5.0 (4.25-5.71)
Measles 27.5 (25.99-28.96) 30.3 (28.72-31.79) 27.4 (25.9-28.88) 14.8 (13.69-16.07)
Rubella 29.1 (27.61-30.64) 30.9 (29.35-32.43) 27.3 (25.79-28.76) 12.7 (11.60-13.82)
Chickenpox 32.6 (31.07-34.19) 16.4 (15.21-17.78) 28.5 (27.01-30.02) 22.5 (21.02-23.80)
Mumps 36.2 (34.59-37.79) 23.7 (22.26-25.10) 31.5 (29.98-33.08) 8.6 (7.66-9.53)
H. influenzae 56.1 (54.4-57.71) 4.1 (3.42-4.74) 39.7 (38.18-41.44) 0.1 (0.01-0.23)
Influenza 44.2 (42.53-45.84) 14.0 (12.87-15.18) 41.8 (40.14-43.43) 0.0
Meningococcus C 53.5 (51.81-55.14) 7.1 (6.24-7.95) 39.4 (37.8-41.06) 0.0
Meningococcus B 57.2 (55.59-58.89) 3.1 (2.49-3.64) 39.7 (38.06-41.32) 0.0
Pneumococcus 57.4 (55.73-59.03) 2.7 (2.18-3.26) 39.8 (38.18-41.44) 0.1 (0.01-0.23)
Hepatitis A 52.2 (50.50-53.84) 7.1 (6.31-8.03) 40.2 (38.56-41.83) 0.0
Papilloma virus 58.7 (57.00-60.29) 1.9 (1.53-2.46) 39.4 (37.79-41.05) 0.0
Herpes zoster 58.9 (57.30-60.58 0.7 (0.47-1.03) 40.0 (38.36-41.63) 0.4 (0.22-0.65)
Tuberculosis 41.5 (39.83-43.11) 24.5 (23.06-25.93) 33.8 (32.26-35.41) 0.3 (0.14-0.50
Tab. II. Vaccination coverage, by age.
  20-30 y (%, CI) 31-40 y (%, CI) 41-50 y (%, CI) 51-60 y (%, CI) 61+ y (%, CI) p < 
Poliomyelitis 77.89 (73.97-81.37) 78.51 (75.51-81.23 78.89 (75.94-81.56) 83.16 (80.68-85.38) 79.84 (75.45-83.61) 0.05
Diphtheria 70.04 (65.81-73.96) 72.69 (69.48-75.69) 71.23 (68.02-74.25) 74.64 (71.81-75.61) 71.24 (66.43-75.61) N.S.
Tetanus 76.03 (72.02-79.63) 76.61 (73.53-79.43) 74.57 (71.45-77.45) 79.36 (76.70-81.79) 75.54 (70.91-79.64) 0.05
Hepatitis B 78.26 (74.36-81.72) 79.90 (76.96-82.55) 75.80 (72.73-78.63) 76.90 (74.15-79.44) 75.81 (71.19-79.89) N.S.
Pertussis 23.14 (19.60-27.11) 29.37 (26.29-32.64) 32.47 (29.33-35.77) 29.98 (27.18-32.93) 30.91 (26.42-35.80) 0.01
Measles 30.17 (26.24-34.41) 32.24 (29.07-35.58) 29.01 (25.99-32.24) 29.98 (27.18-32.93) 30.65 (26.17-35.52) N.S.
Rubella 28.51 (24.66-32.70) 31.23 (28.09-34.54) 32.10 (28.97-35.40) 30.80 (27.98-33.77) 31.45 (26.93-36.35) N.S.
Mumps 21.28 (17.86-25.16) 24.78 (21.89-27.91) 23.46 (20.66-26.50) 24.23 (21.64-27.02) 23.92 (19.86-28.53) N.S.
Influenza 8.26 (6.12-11.07) 14.16 (11.90-16.77) 14.94 (12.64-17.56) 15.30 (13.17-17.70) 15.59 (12.25-19.64) 0.001
Tab. III. Vaccination coverage, by working sector.
Clinical sector (%, CI) Surgical sector (%, CI) Service sector (%, CI) p < 
Poliomyelitis 81.40 (79.02-83.56) 82.78 (80.35-84.97) 81.82 (78.91-84.40) N.S.
Diphtheria 72.98 (70.32-75.50) 73.54 (70.76-76.15) 73.39 (70.12-76.41) N.S.
Tetanus 75.38 (72.78-77.80) 76.75 (74.07-79.23) 77.34 (74.22-77.88) N.S.
Hepatitis B 73.76 (71.11-76.25) 77.24 (74.57-79.70) 79.71 (76.70-82.42) 0.05
Pertussis 28.01 (25.47-30.71) 30.45 (27.71-33.33) 31.09 (27.90-34.48) N.S.
Measles 27.81 (25.27-30.50) 28.99 (26.29-31.84) 28.72 (25.61-32.05) N.S.
Rubella 28.61 (26.05-31.32) 31.03 (28.27-33.93) 30.57 (27.39-33.94) N.S.
Mumps 21.97 (19.65-24.48) 24.32 (21.79-27.04) 22.00 (19.20-25.09) N.S.
Chickenpox 18.60 (16.44-20.98) 17.61 (15.40-20.06) 18.18 (15.60-21.09) N.S.
Influenza 17.54 (15.43-19.87) 13.62 (11.65-15.86) 13.70 (11.43-16.34) N.S.
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Higher coverage was observed among men than women; 
this is in contrast with the literature data, where the high-
er rates in women are due to the prevention of risks re-
lated to some infections in pregnant women [27, 28, 29]. 
Our finding may be linked to the high percentage of 
HCWs who filled “not remember” or did not reported 
their vaccination status.
As regards age, the youngest showed higher rates of vac-
cination against hepatitis B although no significance dif-
ference was found. The seasonal influenza vaccination 
coverage was higher in ≥ 61 years subjects (p < 0.001) 
although VC was very far from the minimum recom-
mended level. These findings are in line with the litera-
ture [8, 9, 17, 30-40].
The international literature reports higher VC rates of phy-
sicians than other healthcare workers [33-35, 41, 42], how-
ever we find this only for hepatitis B and rubella. This 
result could be explained on the hand with high percent-
age of physicians who did not declared their vaccina-
tion status, on the other hand with the high percentage of 
HCWs who did not report their professional profile. The 
highest coverage rates were found in pediatric workers 
(data not shown) but the differences between these and 
other clinical groups were not statistically significant. 
Although international literature data on vaccination 
coverage among pediatricians are limited, higher cover-
age rates and more positive attitudes towards vaccina-
tions have been reported [7, 12, 36, 43].
Limited differences were found based on the working 
sector, higher rates of VC were found among staff work-
ing in services than among workers in either surgical or 
medical departments only for hepatitis B.
The low vaccination coverage for all vaccines could 
be explained by the fear of adverse effects, despite the 
fact that many scientific studies, systematic reviews and 
meta-analyses of the literature have shown such fears to 
be groundless [44-47]. In order to combat “vaccine hesi-
tancy” among HCWs, it is essential to promote clear and 
effective communication regarding vaccinations and to 
adopt innovative strategies (e.g. promoting vaccination 
via social networks and the mass media, training HCWs, 
providing vaccination in the workplace) [48, 49]. 
Vaccine-hesitant HCWs might also deter patients’ vac-
cination uptake [49]. Another issue detected in our study 
was the high percentage of HCWs who declared not re-
calling what vaccinations they had received; this prob-
ably reflects a lax attitude and a lack of confidence in 
vaccination. HCWs should understand that all vaccines 
are safe and useful; they should regard vaccination both 
as a right and as a duty, in order to protect themselves 
and their patients [37].
A major strength of the present study is that it was a 
multicenter study involving several centers located in 
northern, central and southern regions of Italy and used 
an official form to collect data on vaccination status. By 
contrast, the fact that the data were self-reported con-
stitutes a limitation. Indeed, many HCWs, especially in 
the older age-groups, may not have recalled which vac-
cinations they had received or might have declared that 
they did not remember, in order to avoid incurring legal 
action. Further, it was not possible evaluating the differ-
ences on propensity to vaccines between HCWs residing 
in North Centre and South Italy as about 30% of HCWs 
did not report their residence and about 40% were resi-
dents in the major islands of Italy (Sicily and Sardinia).
In conclusion, the question of vaccination among HCWs 
is challenging and fraught with ethical issues. Manda-
tory measures may be needed in order to achieve bet-
ter coverage, such as those implemented by the regional 
Laws of Emilia Romagna, Marche and Puglia [50-52]. 
Mandatory policies are currently under debate in several 
countries, and high-quality studies would help policy-
makers and stake-holders to shape evidence-based ini-
tiatives and programs to improve VC and the control of 
infectious diseases through the correct application of 
guidelines on prevention [53, 54].
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Tab. IV. Vaccination coverage reported by different categories of HCWs.
Physicians (%, CI) Nurses (%, CI)
Other healthcare workers 
(%, CI)
p < 
Poliomyelitis 78.38 (76.22-80.41) 81.96 (78.65-84.85) 82.60 (78.18-86.27) 0.05
Diphtheria 71.92 (69.58-74.15) 72.51 (68.78-75.96) 74.04 (69.11-78.43) 0.05
Tetanus 78.05 (75.87-80.08) 76.73 (73.15-79.96) 76.40 (71.58-80.62) N.S.
Hepatitis B 79.45 (77.31-81.43) 76.56 (72.98-79.80) 72.57 (67.57-77.06) 0.01
Pertussis 28.08 (25.85-30.42) 31.20 (27.59-35.04) 29.59 (24.96-34.67) N.S.
Measles 32.73 (30.39-35.16) 30.86 (27.27-34.70) 30.68 (26.00-35.80) N.S.
Rubella 31.87 (29.53-34.27) 31.70 (28.08-35.56) 31.56 (26.83-36.71) 0.05
Mumps 24.58 (22.45-26.84) 23.10 (19.88-26.67) 25.96 (21.57-30.89) N.S.
Chickenpox 13.94 (12.27-15.80) 19.93 (16.88-23.31) 16.81 (13.20-21.18) 0.001
Influenza 11.38 (9.86-13.10) 14.00 (11.43-17.03) 17.40 (13.73-21.82) 0.001
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